NCT04965402View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986166

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (1)

90630

West Coast Clinical Trials Global, Cypress

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04965402 - A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Participants | Biotech Hunter | Biotech Hunter